Skip to main content
logo
Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.51
-0.13 (-2.30%)
At close: Nov 6, 2026, 4:00 PM EST
5.40
-0.11 (-2.00%)
After-hours: Nov 6, 2026, 4:06 PM EST

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Development and Commercialization of Prophylactic Vaccines
174.66M169.58M153.71M361.30M348.09M
Total
174.66M169.58M153.71M361.30M348.09M

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
53.61M48.59M32.96M-23.80M40.34M
Canada
30.13M32.32M28.19M18.90M4.23M
Germany
17.47M18.37M13.50M68.53M726.00K
Rest Of World
8.90M4.69M16.31M17.36M134.00K
Nordics
13.90M13.94M12.70M12.04M2.44M
United Kingdom
12.64M19.49M20.27M181.13M2.71M
Other Europe
13.88M9.06M9.34M18.74M2.08M
France
14.67M7.22M5.87M46.61M1.00M
Austria
9.47M15.90M14.58M21.79M9.34M
Total
174.66M169.58M153.71M361.30M62.98M